Most people these days agree that it simply doesn't flush your system at all. Niacin, which is also known as vitamin b3, vitamin PP and nicotinic acid, is an organic compound. Depending on the definition that's used, too, the compound is one of the eighty essential human nutrients (though some say there are only forty essential human nutrients). The compound is water-soluble, solid and colorless. It is also a derivative of pyridine, within the carboxyl group and is found at the 3 position. There are other forms of vitamin b3, though, and they include the relevant amide, nicotinamide, as well as more complex amides. There is also a variety of esters.
Niacin is amongst the five vitamins that are associated with vitamin C deficiency (or scurvy), niacin deficiency (or pellagra), thiamin deficiency (or beriberi), vitamin A deficiency and of course vitamin D deficiency (this is rickets).
Niacin has been used in the past, too, in order to increase levels of HDL cholesterol within the blood. The compound has also been found to decrease the risk of cardiovascular events on a small scale. This has been found in only a few controlled human trials.
Though, in a more recent scientific trail, the slow release form of niacin (AIM-HIGH) was found to have absolutely no effect on cardiovascular events. Furthermore, stroke risk was not affected within a group of patients who had LDL levels that were already controlled by a statin drug. The trial was halted early based on evidence that niacin was actually increasing the risk of strokes in this group of individuals. The role of niacin in treating cardiovascular patients remains under heated debate and conversation to this day. Many people believe that the compounds can 'flush out your system', but in truth it cannot.
Niacin is amongst the five vitamins that are associated with vitamin C deficiency (or scurvy), niacin deficiency (or pellagra), thiamin deficiency (or beriberi), vitamin A deficiency and of course vitamin D deficiency (this is rickets).
Niacin has been used in the past, too, in order to increase levels of HDL cholesterol within the blood. The compound has also been found to decrease the risk of cardiovascular events on a small scale. This has been found in only a few controlled human trials.
Though, in a more recent scientific trail, the slow release form of niacin (AIM-HIGH) was found to have absolutely no effect on cardiovascular events. Furthermore, stroke risk was not affected within a group of patients who had LDL levels that were already controlled by a statin drug. The trial was halted early based on evidence that niacin was actually increasing the risk of strokes in this group of individuals. The role of niacin in treating cardiovascular patients remains under heated debate and conversation to this day. Many people believe that the compounds can 'flush out your system', but in truth it cannot.